Stocks and Investing Stocks and Investing
Wed, August 2, 2023

Raghuram Selvaraju Reiterated (TRDA) at Strong Buy and Held Target at $25 on, Aug 2nd, 2023


Published on 2024-10-28 05:23:13 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Reiterated "Entrada Therapeutics, Inc." (TRDA) at Strong Buy and Held Target at $25 on, Aug 2nd, 2023.

Raghuram, nor any peers, have made any analyst calls on TRDA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources